Background: Non-invasive prenatal testing (NIPT) has been available in Australia on a user-pays basis since 2012. Since its introduction, it has grown in popularity as a screening method for fetal aneuploidy and may become publicly funded.
INTRODUCTION
Prenatal tests commonly screen for chromosomal conditions such as trisomy 21 (Down syndrome). In Victoria, yearly uptake for the most common publicly funded screening method, combined first trimester screening (CFTS), is consistently more than 80% of pregnancies. 1 A newer screening method is non-invasive prenatal testing (NIPT). NIPT is based on cell-free fetal DNA (cffDNA) in the maternal bloodstream. A blood sample is taken from the mother, and cffDNA is analysed to produce a probability of the fetus having a chromosomal condition. 2 However, NIPT is not diagnostic for the trisomy disorders 2 and any high-risk result should be confirmed with invasive diagnostic testing, such as amniocentesis.
Non-invasive prenatal testing has many benefits over CFTS.
NIPT is more accurate, with a very high sensitivity and specificity for trisomy 21 (>99%). 2 NIPT outperforms CFTS in both low-and high-risk populations. 3 NIPT can also be performed earlier in the pregnancy, usually from 10 weeks gestation. 4 Non-invasive prenatal testing became available on a user-pays basis to Victorian women in 2012, and this was associated with a 22.9% reduction in invasive testing, 5 due to the much lower falsepositive rate of NIPT compared to CFTS. 1 Availability of NIPT has had similar impacts on number of referrals for diagnostic tests in other healthcare systems. 6 Non-invasive prenatal testing in Australia currently costs approximately AUD$450. 7 Although this is less expensive than many other countries, cost remains the major barrier to widespread uptake. 8 NIPT is being implemented in other public healthcare systems such as the NHS in the United Kingdom. 9 Critical questions remain for possible implementation of NIPT in Australian public healthcare, such as the criteria for access to screening. 10 Women have reported positive experiences with NIPT, emphasising accuracy, ease and safety. 11, 12 These aspects of NIPT have also emerged as important motivators for women to use it; other reasons include seeking reassurance and how early in the pregnancy NIPT can be done. 13 Concerns have been raised about the impact that routinisation of NIPT may have on informed choice; however, previous research has found high levels of informed choice among women who have undergone NIPT. 14, 15 There is limited literature assessing experiences with NIPT in the Australian context. 16, 17 In this study, we aimed to examine the experiences and motivations of women who had undergone NIPT through the Victorian Clinical Genetics Services (VCGS) in Victoria, Australia.
MATERIALS AND METHODS
One thousand women who had undergone the percept™ NIPT through VCGS were selected using systematic sampling (every fifth name from a selected point) from a list of 14 680 referrals in 2016. They were contacted by post in two rounds of 500 (October 2017 and February 2018) and asked to complete a survey, either online in REDCap or through hard copy. Those under the age of 18 were excluded. Respondents were advised that by commencing the survey they were consenting to use of their response data. 
RESULTS
The number of women who responded to the survey was 237. Two were excluded as they did not specify age, and therefore were ineligible to participate. Demographic features are seen in Table 1 .
Reasons for undergoing NIPT
Many respondents (n = 200, 85.8%) indicated that detecting chromosomal abnormalities was a reason they underwent NIPT ( Fig. 1) . A minority of 31.3% (n = 73) wanted to determine fetal sex ( Fig. 1 ). Advice from a medical professional was also a prevalent response, with 38.2% (n = 89) indicating this was a reason for undergoing testing ( Fig. 1) .
Seeking reassurance and 'peace of mind' emerged as important motivators for undergoing NIPT, with 56% (n = 131) of respondents selecting it ( Fig. 1 ). This was reflected in the open-ended responses.
Having the NIPT results available provided much reassurance that we wouldn't have had otherwise and essentially assisted in our choice not to have an amniocentesis to further investigate.
(#47, 31-35, no increased risk)
The NIPT testing brought me so much peace of mind… in my pregnancy…small cost to pay for peace of mind.
(#26, 36-40, no increased risk)
Twenty-three percent of women (n = 54) were motivated to undergo NIPT to avoid invasive testing ( Fig. 1 ). Respondent #43 (36-40, no increased risk) highlighted the ease and non-invasiveness of NIPT.
In comparison [to amniocentesis], the NIPT test was a fair [sic] quicker procedure, obviously no different to a
blood test, and far less stressful…I would highly recom-mend…to certainly undergo the NIPT test, rather than an amniocentesis.
Service providers
The primary treating professional was a private obstetrician in 69% (n = 156) of cases, while 27.9% (n = 63) indicated they were primarily treated by a general practitioner (n = 2), public hospital obstetric unit (n = 30), or combination thereof (n = 31; Fig. 2 ). Only 2.2% (n = 5) indicated that they were primarily treated by a midwife (Fig. 2 ).
Attitudes toward funding
Respondents were favourable toward NIPT being integrated into public healthcare ( Fig. 3 ). Respondents indicated an interest in ensuring public funding was directed to where it was perceived as 'necessary', excluding non-medical traits.
More important that the testing is available and government subsidised than to have an expensive fancy test that provides results that really are inconsequential.
(#166, 41 + , no increased risk)

Test results
The majority of women received a low-risk result (97.8%, n = 227).
Three women (1.3%) received a high-risk result for a trisomy disorder, one woman (0.4%) received a high-risk result for a sex chromosome aneuploidy (false positive), and one woman (0.4%) indicated a highrisk result of 'other'. Therefore, the proportion of women who received any high-risk result was 2.2%, comparable to the overall number of high-risk results from the percept test (2.1%, internal VCGS data).
The three women who received a high-risk result for a trisomy disorder confirmed the diagnosis with invasive testing, and all three opted for termination of pregnancy.
Experience with the NIPT process
Women's experiences with NIPT were generally positive ( Table 2) .
Most respondents (n = 218, 94%) felt they were provided with adequate information on the nature of the test and possible results.
Most respondents (n = 219, 95%) also indicated they would probably or definitely undergo NIPT again. However, of the other four respondents who received high-risk results, all indicated that they were 'mostly' (n = 1) or 'definitely' The respondents in our study were generally highly educated, wealthy and in a stable relationship (see Table 1 ), indicating high socioeconomic status. This is consistent with a previous study that showed women receiving NIPT-indicated diagnoses in Victoria are more advantaged than those receiving diagnoses from other methods such as CFTS. 19 This is unsurprising considering NIPT's cost. These results suggest NIPT is less accessible to women of low socioeconomic status, which would change if the test becomes publicly funded.
The most common primary treating professional was a private obstetrician (69%, Fig. 2) . A 2015 study of Australian and New Zealand medical professionals found there was no significant difference between those working in public and private care offering NIPT to high-risk women, with cost remaining the main access barrier. 16 It is plausible private professionals may offer NIPT more frequently to low-risk women (a category covering most respondents) than public healthcare professionals. However, it is equally possible low-risk women most likely to be interested in NIPT
seek out private care. Further research into the understanding of health professionals about NIPT and screening options may shed further light on these results.
The mean gestational age at blood draw for the VCGS cohort capturing the respondents in this sample was 11.0 ± 1.9 weeks, with approximately 80% of the total cohort using NIPT as their primary screening test. 20 Approximately half the respondents were under the age of 35 at the time of completing the survey.
Therefore, demand from a low-to average-risk population appears to be high. In addition to the VCGS data, an audit of Australian women who had undergone NIPT up until the end of 2013 found that 21% had no specific risk factor indicating need for a referral (eg advanced age or high-risk CFTS result). 21 A 2016 study of 5267 Australian women found nearly two-thirds had used NIPT as a first-line screen, usually under 11 weeks gestation. 22 Analysis of over 900 000 worldwide Harmony NIPT tests (Ariosa Diagnostics, San Jose, CA, USA) suggest the demand from the low-risk population for NIPT is increasing, 23 which is supported by our results.
Most respondents were not supportive of the current userpays system and would prefer some form of government funding. NIPT is becoming integrated into several public healthcare systems, such as the NHS. 24 It is possible that NIPT will become subsidised through the Australian Medicare system, with applications having been made. 25 Our results suggest women who have Respondent #43's comment that NIPT is 'no different to a blood test' is echoed by the statement that it is 'just a blood test' found throughout the literature. 9, 26, 27 This study had several limitations. It addressed women who had NIPT within the current context of its provision in Australia, which is user-pays (at time of writing, costing AUD$449 7 ). Therefore, respondents were generally of high socioeconomic status. Women who are of lower socioeconomic status or referred from the public healthcare system may have different experiences. It was also biased toward those who were proactive in responding to the survey; the response rate was relatively low. This may result in, for example, responses from those with particularly positive or negative experiences of NIPT. Very few respondents had a high-risk result, and therefore the views may be generally representative only of those who had a low-risk result.
The findings of this study suggest that overall, women have positive experiences with NIPT and support implementation into the Australian public healthcare system. Additional development of pre-and post-test counselling was identified as an area of importance to ensure informed consent. The data from this study support further in-depth qualitative research into the motivations and experiences of women who have undergone NIPT, particularly important as it becomes more common as a prenatal screening option. 
